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Abstract: Bitter melon (Momordica charantia) is an alternative therapy that has primarily been used 
for lowering blood glucose levels in patients with diabetes mellitus. Bitter melon's hypoglyecemic 
ingredients have been shown in animal and human studies. 
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Kudret Narı (Momordica charantia) ve Diyabet Hastalığında Etkileri 
 
Özet: Kudret narı (Momordica charantia) diyabetli hastaların kan glukoz seviyelerinin düşürülmesi 
için kullanılmış öncelikli bir alternatif tedavidir. Hayvan ve insanlarda yapılan çalışmalar kudret 
narında hipoglisemik maddelerin var olduğunu göstermiştir. 
 
Anahtar Kelimeler: Kudret narı, Diyabet, Hipoglisemik etki. 
 
Purpose 
Insulin is the mainstay for patients with type 1 diabetes and it is also important in type 
2 when blood glucose levels cannot be controlled by diet, weight loss, exercise and oral 
medications (Kumar and Clark, 2002).  
Clinical conditions for which M. charantia extracts (primarily from the fruit) are 
currently being used include diabetes, dyslipidemia, microbial infections, and potentially as 
a cytotoxic agent for certain types of cancer.  
In numerous studies, at least three different groups of constituents found in all parts of 
momordica have clinically demonstrated hypoglycemic properties or other actions of 
potential benefit against diabetes mellitus (Sharma et al., 2009). 
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Bitter Melon increase the number of beta cells in the pancreas. Bitter melon has been 
shown to increase the number of beta cells in the pancreas thereby improving the body's 
ability to produce insulin (Shetty et al., 2005). 
 
The Mechanisms of Action 
These blood sugar lowering chemicals include a mix of steroidal saponins (known as 
charantins), insulin-like peptides, and alkaloids. Charantin is composed of a mixture of 
beta-sitosterol-beta-D-glucoside and 5.25 stigmadien-3-beta-ol glycoside. This 
hypoglycemic effect is more pronounced in the fruit of bitter melon where these chemicals 
are found in greater abundance (Kumar et al., 2010). 
Momordica also contains an insulinlike polypeptide, polypeptide-P, which lowers 
blood sugar levels when injected subcutaneously into type 1 diabetic patient. Polypeptide-p, 
a plant insulin, charantin, vicine, glycosides, and karavilosides improve blood sugar levels 
by increasing glucose uptake and glycogen synthesis in the liver, muscles, and fat cells 
(Yadav et al., 2005).   
Momordica charantia increase glucose utilization by liver, decrease gluconeogenises 
via inhibition of two key enzyme glucose -6-phasphat and fructose -1,6 bisphosphatase and 
improve glucose oxidation through the shunt pathway by activating glucose -6-phasphate 
dehydrogenase (Shibib et al., 1993; Platel and Srinivasan, 1997). 
Bitter melon (Momordica charantia) extract promotes a balanced storage of glucose in 
the liver as glycogen, supports healthy insulin secretion by the islets of Langerhans, 
promotes peripheral glucose utilization, and healthy serum protein levels according to in 
vivo and in vitro studies. 
Bitter melon is another botanical that has reduced insulin resistance in animals, partly 
through its ability to improve the function of insulin receptors in the liver. It also been 
widely researched in animal studies for its ability to improve glucose and insulin tolerance 
(Nerurkar et al., 2008). 
Fruit juice extracts of M. charantia can stimulate glucose and amino acid uptakes into 
L6 muscle cells just like insulin. A research indicates MC extracts modify the immune 
response in cancer patients via decreased intestinal secretion of interleukin-7, reduced 
lymphocyte number, and increased T-helper and natural killer cell populations (Manabe et 
al., 2003). 
In rats, oral bitter melon juice has been found to potentiate the glucose-lowering effects 
of the sulfonylurea tolbutamide (Cummings et al., 2004). 
Bitter melon notably contains phyto-nutrient, polypeptide-P; a plant insulin known to 
lower blood sugar levels. In addition it also contain hypoglycemic agent called charantin. 
Charantin increases glucose uptake and glycogen synthesis in the cells of liver, muscle and 
adipose tissue. Together, these compounds are thought to be responsible for reduction of 
blood sugar levels in the treatment of type-2 diabetes. They also improve insulin release 
from pancreatic beta cells, and repair or promote new growth of insulin-secreting beta cells. 
p-Insulin, a polypeptide from the fruits and seeds rapidly decreased and normalized the 
blood sugar level in rats (Sarkar et al., 1996). 
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Studies have shown both the aqueous and alcoholic extracts of the fruit possess 
hypoglycaemic activity in streptozotocin-induced diabetic rats by inhibiting the enzyme 
fructose 1, 6-diphosphatase and glucose 6 phosphatase and at the same time stimulating the 
enzyme glucose 6 phosphate dehydrogenase (Bailey et al., 1990; Kulkarni and Gaitonde, 
1962). 
Blood sugar support can be achieved by taking a combination of bitter melon, N-acetyl 
cysteine, goat’s rue, cinnamon, vanadium, quercetin, vitamin C, vitamin E and B6. 
Components of bitter melon (Momordica charantia) extract appear to have structural 
similarities to animal insulin (Basch et al., 2003). 
At least three different groups of constituents in the bitter gourd appeared to have 
hypoglycemic, blood sugar lowering, actions of potential benefit in diabetes mellitus. It is 
believed that these include a mixture of steroidal saponins known as charantin, insulin-like 
peptides, and alkaloids. The bitter melon is believed to improve glucose tolerance in Type 
II diabetes. Active constituents are believed to be oleanolic acid glycosides and Momordins 
which prevent absorption of sugar (Mitra and Bhattacharya, 2006). 
Vanadyl sulfate can work with goat’s rue, bitter melon, and quercetin to help support 
healthy blood sugar levels. In one of the newest studies on this mineral, it protected against 
damaging changes that occurred in the aortas of rats with experimental diabetes (Akgün et 
al., 2007). 
 
Conclusion 
This fruit has also shown the ability to enhance cells’ uptake of glucose, to promote 
insulin release, and to potentiate the effect of insulin (Jayasooriya et al., 2000).  
 Bitter melon has reduced blood glucose and lipids in both normal and diabetic 
animals, protected beta cells, enhanced insulin sensitivity and reduced oxidative stress 
(Shih et al., 2009).  
M. charantia fruit juice acts like insulin to exert its hypoglycaemic effect and 
moreover, it can stimulate amino acid uptake into skeletal muscle cells just like insulin. 
Some studies have suggested that M. charantia juice and its extract can stimulate peripheral 
glucose uptake and moreover, regulate the amount of glucose taken up by the gut (Platel 
and Srinivasan, 1997). 
Bitter melon is used medicinally mainly for the treatment of type 2 diabetes mellitus. 
Some preliminary evidence suggests that the consumption of bitter melon as a whole fruit, 
extract or dried powder may reduce blood sugar levels. Adaptogenic properties are 
indicated by the delay in the appearance of cataracts, the secondary complications of 
diabetes and relief in neurological and other common symptoms even before the 
hypoglycaemia occurred (Oishi et al., 2007). 
Taken together, the results support the beneficial use of M.charantia in the treatment of 
diabetes mellitus. Adverse effects are also known. Nevertheless, bitter gourd has the 
potential to become a component of the diet or a dietary supplement for diabetic and 
prediabetic patients. 
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In obese humans with diabetes, vanadyl sulfate may improve a defect in insulin 
signaling speciﬁc to type 2 diabetes. Bitter melon can help protect against free radical 
damage while supporting healthy insulin levels. 
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